[(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate

C25H37BrO5 — CID 12020359

IUPAC[(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@]23CO[C@H](C[C@H]4[C@@H]5CC[C@H]([C@@H](C)OC(C)=O)[C@@]5(C)CC[C@@H]42)[C@@]3(Br)C1
InChIInChI=1S/C25H37BrO5/c1-14(30-15(2)27)19-5-6-20-18-11-22-25(26)12-17(31-16(3)28)7-10-24(25,13-29-22)21(18)8-9-23(19,20)4/h14,17-22H,5-13H2,1-4H3/t14-,17+,18+,19-,20+,21+,22-,23-,24+,25+/m1/s1
InChIKeyYAMWFWAEIDGPRR-DOPZYHKDSA-N
MW497.47 g/mol
LogP5.03
Rot. Bonds3

About [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate

[(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate (PubChem CID 12020359) has the molecular formula C25H37BrO5 and a molecular weight of 497.47 g/mol. Its IUPAC name is [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate.

Molecular Properties

Compound Name[(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate
PubChem CID12020359
Molecular FormulaC25H37BrO5
Molecular Weight497.47 g/mol
Exact Mass496.18
IUPAC Name[(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@]23CO[C@H](C[C@H]4[C@@H]5CC[C@H]([C@@H](C)OC(C)=O)[C@@]5(C)CC[C@@H]42)[C@@]3(Br)C1
InChIInChI=1S/C25H37BrO5/c1-14(30-15(2)27)19-5-6-20-18-11-22-25(26)12-17(31-16(3)28)7-10-24(25,13-29-22)21(18)8-9-23(19,20)4/h14,17-22H,5-13H2,1-4H3/t14-,17+,18+,19-,20+,21+,22-,23-,24+,25+/m1/s1
InChIKeyYAMWFWAEIDGPRR-DOPZYHKDSA-N
XLogP5.03
TPSA61.83 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500497.47
LogP ≤ 55.03
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate?
The IUPAC name of [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate (CID 12020359) is [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate.
What is the SMILES notation for [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate?
The canonical SMILES for [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate is CC(=O)O[C@H]1CC[C@]23CO[C@H](C[C@H]4[C@@H]5CC[C@H]([C@@H](C)OC(C)=O)[C@@]5(C)CC[C@@H]42)[C@@]3(Br)C1.
What is the InChIKey of [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate?
The InChIKey is YAMWFWAEIDGPRR-DOPZYHKDSA-N. The full InChI is InChI=1S/C25H37BrO5/c1-14(30-15(2)27)19-5-6-20-18-11-22-25(26)12-17(31-16(3)28)7-10-24(25,13-29-22)21(18)8-9-23(19,20)4/h14,17-22H,5-13H2,1-4H3/t14-,17+,18+,19-,20+,21+,22-,23-,24+,25+/m1/s1.
What are the key properties of [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate?
[(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate has a molecular weight of 497.47 g/mol, XLogP of 5.03, 3 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,2S,5S,6S,9S,10S,12R,13R,15S)-6-[(1R)-1-acetyloxyethyl]-13-bromo-5-methyl-19-oxapentacyclo[10.5.2.01,13.02,10.05,9]nonadecan-15-yl] acetate is sourced from PubChem (CID 12020359), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).